Search Results - "Bisserbe, J.C."

Anxiolytic and hypnotic use in 376 psychiatric inpatients by Hardy, P, Payan, C, Bisserbe, J.C, Lepine, J.P

“…This objectives of this study were three-fold: retrospectively evaluate anxiolytic/hypnotic consumption by psychiatric inpatients, identify the risk factors of…”
Get full text

S.17.03 Clinical and neurobiolological evidence for efficacy of drug treatment in childhood-onset OCD by Flament, M.F., Irak, M., Bisserbe, J.C.

Get full text

SAT-6-4 Advances in the pharmacotherapy of obsessive-compulsive disorder by Bisserbe, J.C.

Get full text

Sertraline in obsessive-compulsive spectrum disorders — A case study series by Bisserbe, J.C., Lane, R.

Get full text

Effect size, placebo response and tolerability in clinical studies in obsessive-compulsive disorder by Bisserbe, J.C., Lane, R.

Get full text

Severe depression: Recognition and treatment by Lecrubier, Y., Bisserbe, J.C.

Get full text

Prevention of recurrent depressive episodes with milnacipran: consequences on quality of life by Rouillon, F., Berdeaux, G., Bisserbe, J.C., Warner, B., Mesbah, M., Smadja, C., Chwalow, J.

“…Background: Depression is now seen as a chronic disabling condition that spans the patient’s lifetime and creates significant medical, economic and quality of…”
Get full text

Severe depression: Recognition and treatment by Lecrubier, Y., Bisserbe, J.C.

Get full text

Polygraphic study of the effects of milnacipran 100 mg on the sleep of depressed in-patients by Faivre, T., Lemoine, P., Bisserbe, J.C., Schwenk, B.

Get full text

Predictors of response to SSRIs in patients with major depression by Bisserbe, J.C., Lane, R., Wiseman, R.

Get full text

Social phobia: Defining thresholds for treatment intervention by Weiller, E., Bisserbe, J.C., Lecrubier, Y.

Get full text

Clinical and Economic Comparison of Sertraline and Fluoxetine in the Treatment of Depression: A 6-Month Double-Blind Study in a Primary-Care Setting in France by Boyer, P, Hotton, J.M, Troy, S, Danion, J.M, Bisserbe, J.C

“…In a double-blind study in a primary-care setting in France, outpatients fulfilling DSM IV criteria for a major depressive episode were randomised to receive…”
Get full text

Anxiolytics-hypnotics use in children and adolescents and their parents by Pélissolo, A., Bouvard, M., Bisserbe, J.C., Lépine, J.P., Mouren-Siméoni, M.C.

Get full text

Cost-utility of miinacipran (Ixel®) in the prevention of recurrent depression by Dardennes, R., Berdeaux, G., Bisserbe, J.C., Lafuma, A., Pribil, C., Fagnani, F.

Get full text

Benzodiazepines use in the medically III population: Impact of psychopathology and somatic morbidity by Pelissolo, A., Bisserbe, J.C., Weiller, E., Boyer, P., Lecrubier, Y.

Get full text

Validation of the french version of PRIME-MD a primary care evaluation of mental disorder by Boyer, P., Bisserbe, J.C., Falissart, B., Spitzer, R.

Get full text

Efficacy of pharmacological treatment in short term anxiety by Boyer, P., Bisserbe, J.C., Patay, M., Lecrubier, Y.

Get full text

Chronic benzodiazepine use in the general population by Boyer, P., Lépine, J.P., Rein, W., Bisserbe, J.C.

Get full text

A six month sertraline fluoxetine comparative study in depressed outpatients: Outcome and costs by Bisserbe, J.C., Boyer, P., Souêtre, E., Hotton, J.M., Troy, S.

Get full text

Psychotropic drugs use in patients with anxious or depressive disorders vs subthreshold syndromes by Bisserbe, J.C., Weiller, E., Boyer, P., Lecrubier, Y.

Get full text